Analysis of the effect of different NKT cell subpopulations on the activation of CD4 and CD8 T cells, NK cells, and B cells

Yang, 2000, CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of Vα24JαQ T cells: A feedback mechanism for immune regulation, J Immunol, 165, 3756, 10.4049/jimmunol.165.7.3756 Smyth, 2002, Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide, Blood, 99, 1259, 10.1182/blood.V99.4.1259 Hayakawa, 2001, Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide, Eur J Immunol, 31, 1720, 10.1002/1521-4141(200106)31:6<1720::AID-IMMU1720>3.0.CO;2-U Metelitsa, 2001, Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells, J Immunol, 167, 3114, 10.4049/jimmunol.167.6.3114 Yang, 2000, Requirement for IFN-γ in IL-12 production induced by collaboration between vα14+ NKT cells and antigen-presenting cells, Int Immunol, 12, 1669, 10.1093/intimm/12.12.1669 Eberl, 2000, Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation, J Immunol, 165, 4305, 10.4049/jimmunol.165.8.4305 Singh, 1999, Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype, J Immunol, 163, 2373, 10.4049/jimmunol.163.5.2373 Kitamura, 2000, α-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells, Cell Immunol, 199, 37, 10.1006/cimm.1999.1602 Kikuchi, 2001, In vitro anti-tumour activity of α-galactosylceramide-stimulated human invariant Vα24+ NKT cells against melanoma, Br J Cancer, 85, 741, 10.1054/bjoc.2001.1973 Duarte, 2004, Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells, J Immunol, 173, 3112, 10.4049/jimmunol.173.5.3112 Sharif, 2002, Regulation of autoimmune disease by natural killer T cells, J Mol Med, 80, 290, 10.1007/s00109-002-0332-8 Kawano, 1998, Natural killer–like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells, Proc Natl Acad Sci U S A, 95, 5690, 10.1073/pnas.95.10.5690 Kawano, 1999, Antitumor cytotoxicity mediated by ligand-activated human Vα24 NKT cells, Cancer Res, 59, 5102 Kim, 2005, NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production, J Exp Med, 201, 41, 10.1084/jem.20041400 Terabe, 2000, NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway, Nat Immunol, 1, 515, 10.1038/82771 Moodycliffe, 2000, Immune suppression and skin cancer development: regulation by NKT cells, Nat Immunol, 1, 521, 10.1038/82782 Takahashi, 2002, Cutting edge: analysis of human V α 24+ CD8+ NK T cells activated by α-galactosylceramide-pulsed monocyte-derived dendritic cells, J Immunol, 168, 3140, 10.4049/jimmunol.168.7.3140 Takahashi, 2000, Analysis of human V α 24+ CD4+ NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells, J Immunol, 164, 4458, 10.4049/jimmunol.164.9.4458 Gumperz, 2002, Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining, J Exp Med, 195, 625, 10.1084/jem.20011786 Kim, 2002, Distinct subsets of human Vα24-invariant NKT cells: cytokine responses and chemokine receptor expression, Trends Immunol, 23, 516, 10.1016/S1471-4906(02)02323-2 Lee, 2002, Distinct functional lineages of human Vα24 natural killer T cells, J Exp Med, 195, 637, 10.1084/jem.20011908 Nieda, 1999, Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner, Hum Immunol, 60, 10, 10.1016/S0198-8859(98)00100-1 van der Vliet, 2001, Potent expansion of human natural killer T cells using α-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15, J Immunol Methods, 247, 61, 10.1016/S0022-1759(00)00272-6 Nishi, 2000, Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V α 24+V β 11+ T cells in vitro, Hum Immunol, 61, 357, 10.1016/S0198-8859(99)00181-0 Brossay, 1998, CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution, J Exp Med, 188, 1521, 10.1084/jem.188.8.1521 Yu, 2005, Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides, Proc Natl Acad Sci U S A, 102, 3383, 10.1073/pnas.0407488102 Parekh, 2004, Quantitative and qualitative differences in the in vivo response of NKT cells to distinct α- and β-anomeric glycolipids, J Immunol, 173, 3693, 10.4049/jimmunol.173.6.3693 Lin, 2004, Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines, Eur J Immunol, 34, 2664, 10.1002/eji.200324834 Nieda, 2004, Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity, Blood, 103, 383, 10.1182/blood-2003-04-1155 Kenna, 2003, NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells, J Immunol, 171, 1775, 10.4049/jimmunol.171.4.1775 Nakajima, 1997, An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction, Immunity, 7, 691, 10.1016/S1074-7613(00)80389-1 Carnaud, 1999, Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells, J Immunol, 163, 4647, 10.4049/jimmunol.163.9.4647 Nishimura, 2000, The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes, Int Immunol, 12, 987, 10.1093/intimm/12.7.987 Johnson-Leger, 1997, The effects of IFN-γ on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice, J Immunol, 159, 1150, 10.4049/jimmunol.159.3.1150